minocycline

(redirected from Arestin)
Also found in: Dictionary, Thesaurus.

minocycline

 [mĭ-no-si´klēn]
a semisynthetic broad-spectrum antibiotic of the tetracycline group; administered orally or intravenously as the hydrochloride salt

minocycline

/mi·no·cy·cline/ (mĭ-no-si´klēn) a semisynthetic broad-spectrum tetracycline antibiotic, used as the hydrochloride salt.

minocycline

(mĭn′ə-sī′klēn′, -klĭn)
n.
A broad-spectrum antibiotic, C23H27N3O7, derived from tetracycline and used usually in the form of its hydrochloride.

minocycline

A broad-spectrum tetracycline which has a longer serum half-life and achieves higher serum levels than simple tetracycline.

Indications
Acne, Lyme disease, MRSA, and other resistant microbes; it is also a recognised disease-modifying anti-rheumatic drug (DMARD).

Adverse effects
Vertigo, diarrhoea, patchy skin pigmentation, autoimmune disease.

minocycline

A TETRACYCLINE antibiotic used to treat ACNE and general infections. Brand names are Aknemin and Minocin.

minocycline

a second-generation, highly lipid-soluble derivative of tetracycline.
References in periodicals archive ?
reported that Arestin plus SRP resulted in mean probing depth reductions of 1.
Clinical trials demonstrate that Arestin is easy to place, is safe and efficacious.
A post-marketing study of 2805 patients treated for periodontal disease with Arestin.
The market comprises drugs such as Periochip, Arestin, Atridox, Periostat and generics like doxycyline and minocycline.
These findings suggest that the combination of ARESTIN and SRP is more effective in targeting bacteria that grow to a greater density in deeper pockets, such as the red complex strain, than SRP alone.
The result of this reduction allows for improved clinical outcomes for patients treated with ARESTIN plus SRP.